Clinical Trial Considerations in Neuro-oncology

Abstract

This article is part of the Topical Collection on Neuro-oncology Keywords Clinical trials I Clinical trial disparities I Clinical trial accrual I Clinical trial design I Response assessment Opinion statementClinical trials play a critical role in discovering new treatments, but the path to regulatory approval can be cumbersome and time consuming. Efforts to increase the efficiency and interpretability of clinical trials within the neuro-oncology community have focused on standardization of response assessment, development of consensus guidelines for clinical trial conduct, decentralization of clinical trials, removal of barriers to clinical trial accrual, and re-examination of patient eligibility criteria.

Progress and prospects of gene therapy in ophthalmology from 2000 to 2022: A bibliometric analysis

“…Clinical trials play a key role in the discovery of new therapeutic strategies, advancing science, and changing clinical practice on the broadest possible scale [ 32 , 33 ]. Two of the strongest references were on LCA, currently in clinical use [ 34 ].…”

Artificial intelligence tools for optimising recruitment and retention in clinical trials: a scoping review protocol

“…Clinical trials are studies conducted in humans to evaluate the effectiveness and safety of an intervention, 4 they play a critical role in the discovery of new treatments and are important practical activity for improving healthcare. 5 In the traditional clinical trial model, the selection and recruitment mechanism of patient cohorts are critical factors that often contribute to trial failures. 6 While a large patient pool does not ensure trial success, recruiting unsuitable patients could increase the likelihood of trial failure.…”